| Biomarker ID | 961 |
| PMID | 22821756 |
| Year | 2012 |
| Biomarker | Prostate health index (phi) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa [No PCa: 36.84 (28.82–46.14) Vs PCa 49.97 (37.75–69.65)] |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | PCa Vs No-PCa |
| Type of Biomarker | Diagnostic |
| Cohort | 160 patients were included in the study, ouut of which 113 did not have prostate cancer and 47 had prostate cancer. |
| Senstivity | 0.66 (95% CI: 0.51–0.7) |
| Specificity | 0.72 (95% CI: 0.64–0.80) |
| AUC | 0.66 (95% CI: 0.57–0.75) |
| Accuracy | NA |
| Level Of Significance | <0.001 |
| Method Used | NA |
| Clinical | No |
| Remarks | Prostate health index (phi) = (p2PSA/fPSA x 100) |
| Clinical Trial Number | NA |
| Degree Of Validity | not validated on independent patient dataset |
| Technical Name | NA |